Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M A Dimopoulos

Showing results (61-70 of 288) with videos related to

Pageof 29
Sort By:
Leukemia & Lymphoma|June 1, 1999
Bone lesions with soft-tissue mass: magnetic resonance imaging diagnosis of lymphomatous involvement of the bone marrow versus multiple myeloma and bone metastasesL A Moulopoulos, M A Dimopoulos, A Vourtsi, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 29, 2015
Carfilzomib and pomalidomide in patients with relapsed and/or refractory multiple myeloma with baseline risk factorsM A Dimopoulos, P Sonneveld, D Siegel, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 1, 1994
2Chlorodeoxyadenosine therapy of patients with Waldenström macroglobulinemia previously treated with fludarabineM A Dimopoulos, D M Weber, H Kantarjian, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 1, 1995
Treatment of Waldenstrom's macroglobulinemia resistant to standard therapy with 2-chlorodeoxyadenosine: identification of prognostic factorsM A Dimopoulos, D Weber, K B Delasalle, et al.
Urology|June 3, 1998
Static cytometry and neural networks in the discrimination of lower urinary system lesionsD Pantazopoulos, P Karakitsos, A Pouliakis, et al.
Leukemia & Lymphoma|July 12, 2003
Bone marrow angiogenesis and progression in multiple myeloma: clinical significance and therapeutic approachV Eleutherakis-Papaiakovou, M Karali, I Kokkonouzis, et al.
American Journal of Hematology|June 1, 1996
HyperCVAD for VAD-resistant multiple myelomaM A Dimopoulos, D Weber, H Kantarjian, et al.
Annals of Hematology|August 20, 2002
Incidence and evolution of monoclonal gammopathy of undetermined significance (MGUS) in GreeceA Anagnostopoulos, A Evangelopoulou, D Sotou, et al.
American Journal of Hematology|February 1, 1996
Pseudohyperphosphatemia in multiple myelomaM Mavrikakis, G Vaiopoulos, P Athanassiades, et al.
The Journal of Urology|March 17, 2004
Adjuvant chemotherapy with paclitaxel and carboplatin in patients with advanced bladder cancer: a study by the Hellenic Cooperative Oncology GroupA Bamias, Ch Deliveliotis, G Aravantinos, et al.
Pageof 29

Showing results (61-70 of 288) with videos related to

Sort By:
Pageof 29
Leukemia & Lymphoma|June 1, 1999
Bone lesions with soft-tissue mass: magnetic resonance imaging diagnosis of lymphomatous involvement of the bone marrow versus multiple myeloma and bone metastasesL A Moulopoulos, M A Dimopoulos, A Vourtsi, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 29, 2015
Carfilzomib and pomalidomide in patients with relapsed and/or refractory multiple myeloma with baseline risk factorsM A Dimopoulos, P Sonneveld, D Siegel, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 1, 1994
2Chlorodeoxyadenosine therapy of patients with Waldenström macroglobulinemia previously treated with fludarabineM A Dimopoulos, D M Weber, H Kantarjian, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 1, 1995
Treatment of Waldenstrom's macroglobulinemia resistant to standard therapy with 2-chlorodeoxyadenosine: identification of prognostic factorsM A Dimopoulos, D Weber, K B Delasalle, et al.
Urology|June 3, 1998
Static cytometry and neural networks in the discrimination of lower urinary system lesionsD Pantazopoulos, P Karakitsos, A Pouliakis, et al.
Leukemia & Lymphoma|July 12, 2003
Bone marrow angiogenesis and progression in multiple myeloma: clinical significance and therapeutic approachV Eleutherakis-Papaiakovou, M Karali, I Kokkonouzis, et al.
American Journal of Hematology|June 1, 1996
HyperCVAD for VAD-resistant multiple myelomaM A Dimopoulos, D Weber, H Kantarjian, et al.
Annals of Hematology|August 20, 2002
Incidence and evolution of monoclonal gammopathy of undetermined significance (MGUS) in GreeceA Anagnostopoulos, A Evangelopoulou, D Sotou, et al.
American Journal of Hematology|February 1, 1996
Pseudohyperphosphatemia in multiple myelomaM Mavrikakis, G Vaiopoulos, P Athanassiades, et al.
The Journal of Urology|March 17, 2004
Adjuvant chemotherapy with paclitaxel and carboplatin in patients with advanced bladder cancer: a study by the Hellenic Cooperative Oncology GroupA Bamias, Ch Deliveliotis, G Aravantinos, et al.
Pageof 29